SGLT2 inhibitors – Sick day management and facility transition
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a novel drug class that was first approved in Australia for managing...
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a novel drug class that was first approved in Australia for managing...
Promoting behaviour change related to health within the realm of diabetes education is more complex than merely disseminating...
Diabetes stigma and discrimination refer to the negative social judgments, stereotypes, prejudice about, and prejudicial...
Sleep is a fundamental component of health and well-being. Inadequate and poor sleep quality are associated with increased...
I remember reading a response to a FacebookTM comment I...
Diabetes is a long-term chronic condition that requires continual clinical input and...
The prevalence of disability in Australia is around 18% (4 million people), encompassing differing types and levels of...